GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaResearch Co Ltd (XKRX:214450) » Definitions » Other Long-Term Liabilities

PharmaResearch Co (XKRX:214450) Other Long-Term Liabilities : ₩4,234 Mil (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is PharmaResearch Co Other Long-Term Liabilities?

PharmaResearch Co's other long-term liabilities for the quarter that ended in Mar. 2024 was ₩4,234 Mil.

PharmaResearch Co's quarterly other long-term liabilities declined from Sep. 2023 (₩5,951 Mil) to Dec. 2023 (₩5,483 Mil) and declined from Dec. 2023 (₩5,483 Mil) to Mar. 2024 (₩4,234 Mil).

PharmaResearch Co's annual other long-term liabilities declined from Dec. 2021 (₩7,194 Mil) to Dec. 2022 (₩6,399 Mil) and declined from Dec. 2022 (₩6,399 Mil) to Dec. 2023 (₩5,483 Mil).


PharmaResearch Co Other Long-Term Liabilities Historical Data

The historical data trend for PharmaResearch Co's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaResearch Co Other Long-Term Liabilities Chart

PharmaResearch Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PharmaResearch Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PharmaResearch Co Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.


PharmaResearch Co Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of PharmaResearch Co's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaResearch Co (XKRX:214450) Business Description

Traded in Other Exchanges
N/A
Address
74 Pangyo-ro 255beon-gil, Bundang-gu, Gyeonggi-do, Seongnam, KOR, 463-400
PharmaResearch Co Ltd formerly Pharma Research Products Co Ltd is a bio pharmaceutical firm which realizes a new treatment paradigm for regenerative medicine. Its products include Rejuran, Rejuvenex, and Re-An eye drops. It also provides medical devices, cosme ceuticals, and dietary supplements.

PharmaResearch Co (XKRX:214450) Headlines

No Headlines